Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 13.3 Million shares of VRNA, which is worth approximately $822 Million. The most recent transaction as insider was on Nov 02, 2021, when has been sold 10,416 shares (Ordinary Shares) at a price of $0.65 per share, resulting in proceeds of $6,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3M
6.75% 3M change
11.34% 12M change
Total Value Held $822 Million

Mark W Hahn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 02 2021
SELL
Open market or private sale
$6,770 $0.65 p/Share
10,416 Reduced 0.07%
15,991,120 Ordinary Shares
Nov 01 2021
SELL
Payment of exercise price or tax liability
$291,103 $0.64 p/Share
454,848 Reduced 2.76%
16,001,536 Ordinary Shares
Aug 02 2021
SELL
Open market or private sale
$8,020 $0.77 p/Share
10,416 Reduced 0.06%
16,456,384 Ordinary Shares
Aug 01 2021
SELL
Payment of exercise price or tax liability
$354,775 $0.78 p/Share
454,840 Reduced 2.69%
16,466,800 Ordinary Shares
May 03 2021
SELL
Open market or private sale
$9,062 $0.87 p/Share
10,416 Reduced 0.06%
16,921,640 Ordinary Shares
May 03 2021
SELL
Payment of exercise price or tax liability
$1,888,979 $0.89 p/Share
2,122,448 Reduced 11.14%
16,932,056 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$30,470 $1.14 p/Share
26,728 Reduced 0.14%
19,054,504 Ordinary Shares
Jan 28 2021
BUY
Grant, award, or other acquisition
-
105,824 Added 0.55%
19,081,232 Ordinary Shares
MWH

Mark W Hahn

Chief Financial Officer
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA